Advertisement

Relationship Between the rs7341475 Polymorphism and DNA Methylation in the Reelin Gene and Schizophrenia Symptoms

  • M. V. AlfimovaEmail author
  • N. V. Kondratyev
  • A. K. Golov
  • S. A. Golubev
  • D. Yu. Galaktionova
  • T. V. Nasedkina
  • V. E. Golimbet
Article

Objectives. To identify relationships between the rs7341475 polymorphism and methylation of the reelin gene on the one hand and the severity of schizophrenia symptomatology and the neuropsychological indicator – semantic verbal fluency (VF) – on the other. Materials and methods. Genotypes at the rs7341475 locus were determined in 556 patients with schizophrenia spectrum disorders. PANSS evaluations were obtained for 549 of these patients and 221 were tested for semantic VF. The relationship between methylation of the reelin 5’ region and promotor and the severity of PANSS syndromes and VF was assessed using data from 35 patients using the five-factor PANSS model. Results. A relationship was found between genotype at the rs7341475 locus and PANSS measures (a sex-genotype interaction effect: F = 2.70, p = 0.020). Male homozygotes for the common G allele showed the lowest levels of positive syndrome. Verbal fluency was linked with the characteristics of the methylation of the reelin gene promoter. Conclusions. The results obtained here suggest that the rs7341475 polymorphism may be related to variation in positive symptomatology in men. At the same time, the pattern of methylation of the reelin gene is important for retention of VF – with higher levels of methylation in the transcription initiation site and low levels in the distal part of the promoter.

Keywords

RELN gene rs7341475 DNA methylation schizophrenia PANSS cognitive deficit 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    A. Guidotti, D. R. Grayson, and H. J. Caruncho, “Epigenetic RELN dysfunction in schizophrenia and related neuropsychiatric disorders,” Front. Cell. Neurosci., 10, 89 (2016),  https://doi.org/10.3389/fncel.2016.00089.CrossRefGoogle Scholar
  2. 2.
    H. Tost and D. R. Weinberger, “RELN rs7341475 and schizophrenia risk: confusing, yet somehow intriguing,” Biol. Psychiatry, 69, No. 5, 19 (2011),  https://doi.org/10.1016/j.biopsych.2010.10.022.CrossRefGoogle Scholar
  3. 3.
    S. Shifman, M. Johannesson, M. Bronstein, et al., “Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women,” PLoS Genetics, 4, No. 2, 28 (2008),  https://doi.org/10.1371/journal.pgen.0040028.CrossRefGoogle Scholar
  4. 4.
    Y. Liu, P. L. Chen, J. McGrath, et al., “Replication of an association of a common variant in the Reelin gene (RELN) with schizophrenia in Ashkenazi Jewish women,” Psychiatr. Genet., 20, No. 4, 184–186 (2010),  https://doi.org/10.1097/YPG.0b013e32833a220b.CrossRefGoogle Scholar
  5. 5.
    D. Yu. Galaktionova, A. E. Gareeva, E. K. Khusnutdinova, and T. V. Nasedkina, “Association of polymorphic markers of the SLC18A1, TPH1, and RELN genes with the risk of developing the paranoid form of schizophrenia,” Mol. Biol. (Mosk.), 48, No. 4, 629–639 (2014),  https://doi.org/10.7868/S0026898414030045.CrossRefGoogle Scholar
  6. 6.
    N. Chen, Y. Bao, Y. Xue, et al., “Meta-analyses of RELN variants in neuropsychiatric disorders,” Behav. Brain Res., 332, 110–119 (2017),  https://doi.org/10.1016/j.bbr.2017.05.028.CrossRefGoogle Scholar
  7. 7.
    J. Wedenoja, A. Tuulio-Henriksson, J. Suvisaari, et al., “Replication of association between working memory and reelin. A potential modifi er gene in schizophrenia,” Biol. Psychiatry, 67, No. 10, 983–991 (2010),  https://doi.org/10.1016/j.biopsych.2009.09.026.CrossRefGoogle Scholar
  8. 8.
    J. Wedenoja, A. Loukola, A. Tuulio-Henriksson, et al., “Replication of linkage on chromosome 7q22 and association of the regional Reelin gene with working memory in schizophrenia families,” Mol. Psychiatry, 13, No. 7, 673–684 (2008),  https://doi.org/10.1038/sj.mp.4002047.CrossRefGoogle Scholar
  9. 9.
    B. T. Baune, C. Konrad, T. Suslow, et al., “The reelin (RELN) gene is associated with executive function in healthy individuals,” Neurobiol. Learn. Mem., 94, No. 4, 446–451 (2010),  https://doi.org/10.1016/j.nlm.2010.08.002.CrossRefGoogle Scholar
  10. 10.
    G. Ovadia and S. Shifman, “The genetic variation of RELN expression in schizophrenia and bipolar disorder,” PLoS One, 6, No. 5, 19955 (2011),  https://doi.org/10.1371/journal.pone.0019955.CrossRefGoogle Scholar
  11. 11.
    Y. Chen, R. P. Sharma, R. H. Costa, et al., “On the epigenetic regulation of the human reelin promoter,” Nucleic Acids Res., 30, No. 13, 2930–2929 (2002).CrossRefGoogle Scholar
  12. 12.
    R. M. Nabil Fikri, A. T. Norlelawati, A. R. Nour El-Huda, et al., “Reelin (RELN) DNA methylation in the peripheral blood of schizophrenia,” J. Psychiatr. Res., 88, 28–37 (2017),  https://doi.org/10.1016/j.jpsychires.2016.12.020.CrossRefGoogle Scholar
  13. 13.
    I. Negrón-Oyarzo, A. Lara-Vásquez, I. Palacios-García, et al., “Schizophrenia and reelin: a model based on prenatal stress to study epigenetics, brain development and behavior,” Biol. Res., 49, No. 1, 16 (2016),  https://doi.org/10.1186/s40659-016-0076-5.CrossRefGoogle Scholar
  14. 14.
    N. Teroganova, L. Girshkin, and C. M. Suter, and M. J. Green, “DNA methylation in peripheral tissue of schizophrenia and bipolar disorder: a systematic review,” BMC Genet., 17, 27 (2016),  https://doi.org/10.1186/s12863-016-0332-2.CrossRefGoogle Scholar
  15. 15.
    R. Alelú-Paz, A. Gonzalez-Corpas, N. Ashour, et al., “DNA methylation pattern of gene promoters of major neurotransmitter systems in older patients with schizophrenia with severe and mild cognitive impairment,” Int. J. Geriatr. Psychiatry, 30, No. 6, 558–565 (2015),  https://doi.org/10.1002/gps.4182.CrossRefGoogle Scholar
  16. 16.
    D. R. Grayson, X. Jia, Y. Chen, et al., “Reelin promoter hypermethylation in schizophrenia,” Proc. Natl. Acad. Sci. USA, 102, No. 26, 9341–9346 (2005),  https://doi.org/10.1073/pnas.0503736102.CrossRefGoogle Scholar
  17. 17.
    C. Lintas, R. Sacco, and A. M. Persico, “Differential methylation at the RELN gene promoter in temporal cortex from autistic and typically developing post-pubertal subjects,” J. Neurodev. Disord., 8, 18 (2016),  https://doi.org/10.1186/s11689-016-9151-z.CrossRefGoogle Scholar
  18. 18.
    M. V. Alfimova, “Semantic verbal fluency: normative data and characteristics of task performance by patients with schizophrenia,” Sotsial. Klin. Psikhiatr., 20, No. 3, 20–25 (2010).Google Scholar
  19. 19.
    J. D. Henry, and J. R. Crawford, “A meta-analytic review of verbal fluency deficits in schizophrenia relative to other neurocognitive deficits,” Cogn. Neuropsychiatry, 10, 1–33 (2005),  https://doi.org/10.1080/13546800344000309.CrossRefGoogle Scholar
  20. 20.
    T. V. Lezheiko and M. V. Alfimova, “Epigenetic studies of cognitive deficit in schizophrenia: some methodological challenges,” Zh. Nevrol. Psikhiat., 117, No. 10, 76–80 (2017),  https://doi.org/10.17116/jnevro201711710176-80.CrossRefGoogle Scholar
  21. 21.
    L. White, P. D. Harvey, L. Opler, and J. P. Lindenmayer, “Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale,” Psychopathology, 30, No. 5, 263–274 (1997),  https://doi.org/10.1159/000285058.CrossRefGoogle Scholar
  22. 22.
    Y. Yang, R. Sebra, B. S. Pullman, et al., “Quantitative and multiplexed DNA methylation analysis using long-read single-molecule real-time bisulfi te sequencing (SMRTBS),” BMC Genomics, 16, 350 (2015),  https://doi.org/10.1186/s12864-015-1572-7.CrossRefGoogle Scholar
  23. 23.
    M. V. Alfimova, N. V. Kondratyev, A. K. Golov, and V. E. Golimbet, “Methylation of the reelin gene promoter in peripheral blood and its relationship with cognitive funcitoning in patients with schizophrenia,” Mol. Biol. (Mosk.), 52, No. 5, 782–792 (2018),  https://doi.org/10.1134/S0026898418050026.CrossRefGoogle Scholar
  24. 24.
    A. V. Bocharova, V. A. Stepanov, A. V. Marusin, et al., “Analysis of associations of genetic markers of schizophrenia and its cognitive endophenotypes,” Genetika, 53, No. 1, 100–108 (2017), https://doi. org/10.1134/S1022795417010033,  https://doi.org/10.7868/S0016675817010039.PubMedGoogle Scholar
  25. 25.
    F. S. Goes, V. L. Willour, P. P. Zandi, et al., “Sex-specific association of the Reelin gene with bipolar disorder,” Am. J. Med. Genet. B. Neuropsych. Genet., 153B, No. 2, 549–553 (2010),  https://doi.org/10.1002/ajmg.b.31018.CrossRefGoogle Scholar
  26. 26.
    Á. Fehér, A. Juhász, M. Pákáski, et al., “Genetic analysis of the RELN gene: Gender specific association with Alzheimer’s disease,” Psychiatry Res., 230, No. 2, 716–718 (2015),  https://doi.org/10.1016/j.psychres.2015.09.021.CrossRefGoogle Scholar
  27. 27.
    A. Schroeder, L. Buret, R. A. Hill, and M. van den Buuse, “Geneenvironment interaction of reelin and stress in cognitive behaviours in mice: Implications for schizophrenia,” Behav. Brain Res., 287, 304–314 (2015),  https://doi.org/10.1016/j.bbr.2015.03.063.CrossRefGoogle Scholar
  28. 28.
    R. A. Hill, Y. W. Wu, A. Gogos, and M. van den Buuse, “Sexdependent alterations in BDNF-TrkB signaling in the hippocampus of reelin heterozygous mice: a role for sex steroid hormones,” J. Neurochem., 126, No. 3, 389–399 (2013),  https://doi.org/10.1111/jnc.12205.CrossRefGoogle Scholar
  29. 29.
    M. den Buuse, P. Halley, R. Hill, et al., “Altered N-methyl-D-aspartate receptor function in reelin heterozygous mice: male-female differences and comparison with dopaminergic activity,” Prog. Neuropsychopharmacol. Biol. Psychiatry, 37, No. 2, 237–246 (2012),  https://doi.org/10.1016/j.pnpbp.2012.02.005.CrossRefGoogle Scholar
  30. 30.
    H. Tost, B. K. Lipska, R. Vakkalanka, et al., “No effect of a common allelic variant in the reelin gene on intermediate phenotype measures of brain structure, brain function, and gene expression,” Biol. Psychiatry, 68, No. 1, 105–107 (2010),  https://doi.org/10.1016/j.biopsych.2010.02.023.CrossRefGoogle Scholar
  31. 31.
    L. Greenbaum, R. Levin, E. Lerer, et al., “Association of reelin (RELN) single nucleotide polymorphism rs7341475 with prepulse inhibition in the Jewish Israeli population,” Biol. Psychiatry, 69, No. 5, 17–18 (2011),  https://doi.org/10.1016/j.biopsych.2010.09.059.CrossRefGoogle Scholar
  32. 32.
    T. A. Greenwood, L. C. Lazzeroni, M. E. Calkins, et al., “Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study,” Schizophr. Res., 170, No. 1, 30–40 (2016),  https://doi.org/10.1016/j.schres.2015.11.008.CrossRefGoogle Scholar
  33. 33.
    H. E. Becker, D. H. Nieman, P. M. Dingemans, et al., “Verbal fluency as a possible predictor for psychosis,” Eur. Psychiatry, 25, 105–110 (2010),  https://doi.org/10.1016/j.eurpsy.2009.08.003.CrossRefGoogle Scholar
  34. 34.
    S. N. Hatton, J. Lagopoulos, D. F. Hermens, et al., “Cortical thinning in young psychosis and bipolar patients correlate with common neurocognitive deficits,” Int. J. Bipolar Disord., 1, 3 (2013), https://doi. org/10.1186/2194-7511-1-3.CrossRefGoogle Scholar
  35. 35.
    W. H. Jung, J. H. Jang, N. Y. Shin, et al., “Regional brain atrophy and functional disconnection in Broca’s area in individuals at ultra-high risk for psychosis and schizophrenia,” PLoS One, 7, 51975 (2012),  https://doi.org/10.1371/journal.pone.0051975.CrossRefGoogle Scholar
  36. 36.
    M. V. Alfimova, I. S. Lebedeva, A. N. Tomyshev, et al., “Verbal fluency at the initial stages of schizophrenia: structural and neurophysiological correlates,” Sotsial. Klin. Psikhiatr., 26, No. 4, 5–11 (2016).Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • M. V. Alfimova
    • 1
    Email author
  • N. V. Kondratyev
    • 1
  • A. K. Golov
    • 1
  • S. A. Golubev
    • 1
  • D. Yu. Galaktionova
    • 2
  • T. V. Nasedkina
    • 2
  • V. E. Golimbet
    • 1
  1. 1.Mental Health Scientific CenterMoscowRussia
  2. 2.Institute of Molecular BiologyRussian Academy of SciencesMoscowRussia

Personalised recommendations